A Dose-escalation Study of LUNA18 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion).
Status:
Recruiting
Trial end date:
2025-03-31
Target enrollment:
Participant gender:
Summary
This is a Phase 1 dose-escalation and cohort expansion study that will evaluate the safety,
pharmacokinetics (PK), pharmacodynamics (PD), and preliminary activity of LUNA18 in patients
with locally advanced or metastatic solid tumors.